651 related articles for article (PubMed ID: 25398335)
1. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.
Pattanayak V; Guilinger JP; Liu DR
Methods Enzymol; 2014; 546():47-78. PubMed ID: 25398335
[TBL] [Abstract][Full Text] [Related]
2. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
[TBL] [Abstract][Full Text] [Related]
3. Origins of Programmable Nucleases for Genome Engineering.
Chandrasegaran S; Carroll D
J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
[TBL] [Abstract][Full Text] [Related]
4. Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9.
Koo T; Lee J; Kim JS
Mol Cells; 2015 Jun; 38(6):475-81. PubMed ID: 25985872
[TBL] [Abstract][Full Text] [Related]
5. Genome editing with engineered nucleases in plants.
Osakabe Y; Osakabe K
Plant Cell Physiol; 2015 Mar; 56(3):389-400. PubMed ID: 25416289
[TBL] [Abstract][Full Text] [Related]
6. Programmable DNA cleavage in vitro by Cas9.
Karvelis T; Gasiunas G; Siksnys V
Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
[TBL] [Abstract][Full Text] [Related]
7. Research progress of genome editing and derivative technologies in plants.
Shan QW; Gao CX
Yi Chuan; 2015 Oct; 37(10):953-73. PubMed ID: 26496748
[TBL] [Abstract][Full Text] [Related]
8. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
9. [CRISPR/Cas system for genome editing in pluripotent stem cells].
Vasil'eva EA; Melino D; Barlev NA
Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
[TBL] [Abstract][Full Text] [Related]
10. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
11. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
12. Genome editing through large insertion leads to the skipping of targeted exon.
Uddin B; Chen NP; Panic M; Schiebel E
BMC Genomics; 2015 Dec; 16():1082. PubMed ID: 26691863
[TBL] [Abstract][Full Text] [Related]
13. Discovering the Genome-Wide Activity of CRISPR-Cas Nucleases.
Tsai SQ
ACS Chem Biol; 2018 Feb; 13(2):305-308. PubMed ID: 29281250
[TBL] [Abstract][Full Text] [Related]
14. Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases.
Hu JH; Davis KM; Liu DR
Cell Chem Biol; 2016 Jan; 23(1):57-73. PubMed ID: 26933736
[TBL] [Abstract][Full Text] [Related]
15. Genome editing technologies to fight infectious diseases.
Trevisan M; Palù G; Barzon L
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
[TBL] [Abstract][Full Text] [Related]
16. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
17. In vitro enzymology of Cas9.
Anders C; Jinek M
Methods Enzymol; 2014; 546():1-20. PubMed ID: 25398333
[TBL] [Abstract][Full Text] [Related]
18. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
19. A guide to genome engineering with programmable nucleases.
Kim H; Kim JS
Nat Rev Genet; 2014 May; 15(5):321-34. PubMed ID: 24690881
[TBL] [Abstract][Full Text] [Related]
20. Guide RNA functional modules direct Cas9 activity and orthogonality.
Briner AE; Donohoue PD; Gomaa AA; Selle K; Slorach EM; Nye CH; Haurwitz RE; Beisel CL; May AP; Barrangou R
Mol Cell; 2014 Oct; 56(2):333-339. PubMed ID: 25373540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
